For the Inventor, By the Inventor

Enter assignee name

Cerenis Therapeutics Holding S.a.

USPTO Granted Patents = 17

CIPO Patents = 9

EPO Patents = 10

Trademarks = 1

Forward Citations = 65

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Jean-Louis Henri Dasseux (15 out of 59 patents)

Daniela Carmen Oniciu (8 out of 13 patents)

Ronald Barbaras (5 out of 7 patents)

4. Rose Ackermann (4 out of 7 patents)

5. Lingyu Zhu (4 out of 5 patents)

6. Anna Shenderova Schwendeman (4 out of 4 patents)

7. Otto Joseph Geoffroy (2 out of 3 patents)

8. Oleg Gennadievich Rodin (2 out of 2 patents)

9. Anna Rzepiela (2 out of 2 patents)

10. Benoit Oswald (2 out of 2 patents)

11. Stefan Heckhoff (2 out of 2 patents)

12. Andreas Peer (2 out of 2 patents)

13. Peter Rebmann (2 out of 2 patents)

14. Miguel Gonzalez (2 out of 2 patents)

15. Patrik Sauter (2 out of 2 patents)

17 patents: Sort by Forward Citations

1. 11376309 - Lipoprotein complexes and manufacturing and uses thereof (2022-07-05),

2. 10328119 - Lipoprotein complexes and manufacturing and uses thereof (2019-06-25),

3. 10322163 - Lipoprotein complexes and manufacturing and uses thereof (2019-06-18),

4. 10220040 - Compounds, compositions and methods useful for cholesterol mobilization (2019-03-05),

5. 9981008 - Apolipoprotein A-I mimics (2018-05-29),

6. 9757381 - Compounds, compositions and methods useful for cholesterol mobilization (2017-09-12),

7. 9713619 - Compounds, compositions and methods useful for cholesterol mobilization (2017-07-25),

8. 9708354 - Methods for the synthesis of sphingomyelins and dihydrosphingomyelins (2017-07-18),

9. 9643915 - Methods for the synthesis of sphingomyelins and dihydrosphingomyelins (2017-05-09),

10. 9567388 - Charged lipoprotein complexes and their uses (2017-02-14),

11. 9388232 - Apolipoprotein A-I mimics (2016-07-12),

12. 9187551 - Lipoprotein complexes and manufacturing and uses thereof (2015-11-17),

13. 9085585 - Compounds, compositions and methods useful for cholesterol mobilization (2015-07-21),

14. 8993597 - Apolipoprotein A-I mimics (2015-03-31),

15. 8378068 - Apolipoprotein A-I mimics (2013-02-19),

Cerenis Therapeutics Holding S.A. is a biopharmaceutical company specializing in the development of innovative cardiovascular and metabolic disease therapies. The company focuses on the discovery and development of HDL (high-density lipoprotein)-based therapies, also known as HDL mimetics, which have the potential to treat a range of cardiovascular and metabolic diseases. Cerenis Therapeutics aims to improve patient outcomes and address unmet medical needs through its cutting-edge research and development efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

17 Patents

#1 in Balma

#1,127 in France

#34,819 in the World

Cerenis Therapeutics Holding S.a.

Forward Citations = 65

19 inventors:

Jean-Louis Henri Dasseux (15 out of 59 patents)

Daniela Carmen Oniciu (8 out of 13 patents)

Ronald Barbaras (5 out of 7 patents)

4. Rose Ackermann (4 out of 7 patents)

5. Lingyu Zhu (4 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…